Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
October 23, 2006
By: Tim Wright
Editor-in-Chief, Contract Pharma
Astellas Pharma, Inc. has chosen Medidata Solutions Rave 5.5 as its standard global solution for all clinical studies in Phases I-III during the next five years. Astellas plans to implement clinical trials using Medidata Rave 5.5 across North America, Asia, Europe and other regions. According to the company, the selection was based on Medidata’s understanding of the requirements of the global clinical development process and its reliable and secure hosting and help desk services and support. Medidata Rave 5.5 is able to support Astellas’ global initiatives on a single scalable platform by offering the flexibility to allow clinicians to capture, manage and report on clinical data simultaneously in the languages of their choice, including support for complete Japanese character sets. “We were impressed with Medidata’s plan in the Japanese market and the company’s unique ability to manage paper trials as well as electronic trials,” said Mitsutoshi Mukai, vice president of data science at Astellas. “With a reliable, scalable and user-friendly technology, Medidata is able to handle our diverse profile of global trials and allow us to focus on our core business of designing clinical programs.” Rave 5.5’s Double Data Entry (DDE) feature will allow Astellas to collect both paper and electronic data in a single database, which provides global access for collaboration and monitoring of activities across various organizations and geographies. Rave 5.5’s Local Language Translation Workbench will also eliminate translation procedures and allow users to work in their native language against a single, global, centrally-managed repository of clinical data. “We are deeply honored for Medidata Rave to have been chosen as Astellas’ electronic clinical data management solution, and share in their vision for streamlining a wide range of clinical trials. This relationship further highlights our success and commitment to delivering outstanding levels of service, quality and reliability,” said Tarek Sherif, chief executive officer of Medidata Solutions. “Medidata’s infrastructure was built to flexibly and cost-effectively scale up or down to manage trials of any size within a company’s portfolio, and we look forward to collaborating with the Astellas team as they standardize their global clinical trial procedures using Rave.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !